Anthony O. CAGGIANO,Anindita GANGULY,Jennifer IACI,Tom PARRY
申请号：
US14772205
公开号：
US20160129084A1
申请日:
2014.03.06
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention relates to treatment and prevention of heart failure in a mammal. The invention provides a dosing regimen whereby the therapeutic benefits conferred by administration of peptide comprising an epidermal growth factor-like domain, e.g., a neuregulin such as glial growth factor 2 (GGF2) or a functional fragment thereof, are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
